Print Friendly, PDF & Email

First indigenous vaccine for infant pneumonia approved

Topics Covered: Issues related to health.

First indigenous vaccine for infant pneumonia approved

The Drug Controller General of India (DCGI) has approved the first fully indigenously developed conjugate vaccine for pneumonia- Pneumococcal Polysaccharide Conjugate Vaccine.

  • It has been developed by the Serum Institute of India Pvt. Ltd,

This vaccine is used for active immunisation against invasive disease and pneumonia caused by “streptococcus pneumonia” in infants.

How is Pneumonia spread?

Infectious agents may include bacteria, viruses and fungi.

Streptococcus pneumoniae is the most common cause of bacterial pneumonia in children, and Haemophilus influenzae type b (Hib) is the second most common cause of bacterial pneumonia. Respiratory syncytial virus is the most common viral cause of pneumonia.

  • Air sacsin an infected individual’s lungs (alveoli) become inflamed due to deposits of fluid and pus, making it painful and difficult for them to breathe.

What are the symptoms of infection?

Symptoms include high fever and chills, cough with phlegm, physical weakness and a feeling of being unwell, shortness of breath and rapid breathing, and a racing pulse.

How can it be prevented and treated?

Preventive measures include maintaining hygiene and getting vaccinations against certain pneumonia causing bacteria.

Saving a child from pneumonia requires urgent treatment, that usually involves the administration of antibiotics, which typically do not cost much. On average, treatment lasts for about five to seven days.

InstaLinks:

Prelims Link:

  1. Pneumonia- types, causes and symptoms.
  2. Antigens vs Antibodies.
  3. How a vaccine works?
  4. Types of vaccines.
  5. About DGCI.
  6. Procedure to be followed for vaccine approval in India.

Sources: the Hindu.